Keyword: Bill and Melinda Gates Foundation
A project that aims to rev up the search for drugs to treat antimicrobial-resistant infections has picked up two more deep-pocketed backers.
Gregory Verdine’s FogPharma raised $66 million in series B financing, with hopes to bring its first product to the clinic by the end of next year.
The Bill & Melinda Gates Foundation has teamed up with big pharma Novartis and its experimental drug for certain diarrheal diseases.
Arsanis is gunning for a $58 million IPO as it seeks a new cash load for its work on using monoclonal antibodies for infectious diseases.
The Bill & Melinda Gates Foundation is investing up to $40 million spur research into the use of TCR-based therapeutics to treat tuberculosis and HIV.